Alana McNulty is our Chief Business Officer. Ms. McNulty recently served as both Chief Business Officer and Chief Financial Officer since July 2019, and as our Chief Financial Officer since July 2012, initially as a consultant. Previously, Ms. McNulty also served as Chief Financial Officer of Lumena Pharmaceuticals Inc., a biopharmaceutical company, from July 2012 until its acquisition by Shire plc in November 2014, and as Chief Financial Officer of Excaliard Pharmaceuticals, Inc., a biopharmaceutical company, from March 2011 through its acquisition by Pfizer Inc. in November 2011. Prior to that, Ms. McNulty was Chief Financial Officer at BrainCells, Inc., a biopharmaceutical company, from 2004 until 2011 and Chief Financial Officer of Elitra Pharmaceuticals Inc., a biopharmaceutical company, from 1998 to 2003. Earlier, Ms. McNulty was head of Corporate Development at Advanced Tissue Sciences where she led all business development activities as well as investor relations until she became the General Manager of a joint venture partnership she had established with Smith&Nephew. Ms. McNulty received a B.A. in Biology with High Honors from the University of California, Santa Barbara where she graduated Phi Beta Kappa, and an M.B.A. from the Anderson School of Business at the University of California, Los Angeles.